Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.47 |
| ▸ | LTA4H | P09960 | 2/20 | 0.46 |
| ▸ | OTC | P00480 | 1/20 | 0.46 |
| ▸ | CXCR3 | P49682 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.43 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.43 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.42 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3862935 | 0.91 | ALDH1A1 (0.50) | ALDH1A1L3MBTL1LTA4HCXCR3TDP1 | |
| SCHEMBL6014960 | 0.82 | HPGD (0.63) | ALDH1A1L3MBTL1KMT2AHDAC1LMNA | |
| SCHEMBL24130547 | 0.81 | HDAC1 (0.58) | ALDH1A1TDP1POLBKMT2AHDAC1 | |
| SCHEMBL345305 | 0.81 | HDAC1 (0.58) | ALDH1A1TDP1POLBKMT2AHDAC1 | |
| SCHEMBL1242961 | 0.81 | HDAC1 (0.58) | ALDH1A1TDP1POLBKMT2AHDAC1 | |
| SCHEMBL2464340 | 0.81 | OTC (0.49) | OTCTDP1POLBKMT2AHDAC1 | |
| SCHEMBL1009383 | 0.81 | OTC (0.49) | OTCTDP1POLBKMT2AHDAC1 | |
| SCHEMBL28134771 | 0.81 | TDP1 (0.67) | L3MBTL1LTA4HTDP1POLBKMT2A | |
| SCHEMBL2159293 | 0.81 | TDP1 (0.60) | ALDH1A1L3MBTL1LTA4HTDP1POLB | |
| SCHEMBL7035941 | 0.80 | POLB (0.48) | LTA4HOTCTDP1POLBKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090176967-A1 | Conjugation of FVII | NOVO NORDISK HEALTHCARE A/G (CH) | 2009-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090176967-A1 | Conjugation of FVII | F13B, F13A1, FGB | ALDH1A1 4528/4885L3MBTL1 1939/4885LTA4H 3008/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.